`
`UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`
`BTG INTERNATIONAL LIMITED,
`et al.,
`
`Civ. No. 15-cv-5909 (KM)(JBC)
`
`Plaintiffs,
`
`V.
`
`ACTAVIS LABORATORIES FL, INC.,
`et al.,
`
`Defendants.
`
`ORDER
`(Markman Patent Claim Construction)
`
`MCNULTY, U.S.D.J.:
`
`The Court in this patent infringement action having held a hearing on
`October 25, 2016, for the purpose of constructing contested terms in the ‘438
`patent at issue, pursuant to Markman v. Westuiew Instnzments, 52 F.3d 967
`(Fed. Cir. 1995); and the Court having considered the submissions, evidence,
`competing constructions of disputed terms, and arguments of the parties; and
`the Court having filed simultaneously herewith an Opinion setting forth its
`reasoning; and good cause appearing therefor;
`
`IT IS this 9th day of November, 2016,
`
`ORDERED, for the reasons expressed in the accompanying Opinion, that
`the disputed terms in the ‘438 patent at issue in this case shall be constructed
`as follows:
`
`(Claim 1) Treatment! treating means the eradication, removal, modification,
`management or control of a tumor or primary, regional, or metastatic cancer
`cells or tissue and the minimization or delay of the spread of cancer.
`
`JANSSEN EXHIBIT 2011
`Wockhardt v. Janssen IPR2016-01582
`
`
`
`Case 2:15-cv-05909-KM-JBC Document 240 Filed 11/14/16 Page 2 of 2 PageID: 4395
`
`DATED: November 10, 2016
`
`((
`1— j
`‘-‘d L/’—’
`/
`KEVIN MCNULTY
`United States District Jude
`
`2